Decitabine Injection is a prescription oncology medicine containing decitabine. A commonly marketed presentation is 50 mg per vial for intravenous administration. U.S. prescribing information lists decitabine for certain adult patients with myelodysplastic syndromes (MDS), while approved indications vary by country.
Cordium Pharmaceuticals Pvt Ltd, an India-based pharmaceutical exporter, provides supply enquiries for Decitabine Injection to hospitals, pharmaceutical distributors, healthcare procurement companies and eligible personal-import customers.
Decitabine Injection Supply at Competitive Price
Cordium Pharmaceuticals supports international supply enquiries for:
Morocco • Kenya • Singapore • Australia • Germany • France • Canada • Saudi Arabia
Competitive pricing can depend on quantity, product presentation, destination, shipping requirements and applicable regulatory documentation. Contact Cordium Pharmaceuticals for a current quotation.
Suitable for
- Hospitals and oncology centres
- Pharmaceutical distributors
- Wholesalers
- Healthcare procurement companies
- Authorized pharmacies
- Eligible personal-import requirements
Decitabine Injection 50 mg
Decitabine is administered by intravenous infusion under qualified medical supervision. Treatment schedules and dosage are determined by the treating oncologist. The U.S. label describes 3-day and 5-day dosing regimens and emphasizes monitoring of blood counts because of the risk of neutropenia and thrombocytopenia.
In the European Union, Dacogen (decitabine) is authorized for certain newly diagnosed adult AML patients who are not candidates for standard induction chemotherapy.
Why Choose Cordium Pharma?
- India-based pharmaceutical exporter
- Competitive quotation support
- International oncology medicine supply
- Hospital and distributor procurement support
- Export documentation assistance
- International shipping coordination
- Professional order handling
- Support for multiple global destinations
International Supply
Cordium Pharmaceuticals can assist with Decitabine Injection supply enquiries for customers in Morocco, Kenya, Singapore, Australia, Germany, France, Canada and Saudi Arabia.
Import permissions, product registration, prescription requirements and customs procedures differ between countries. Buyers should verify and comply with applicable local regulations before ordering.
FAQs
What is Decitabine Injection?
Decitabine Injection is a prescription oncology medicine containing decitabine and is administered intravenously under medical supervision.
What strength is commonly available?
A commonly marketed presentation is Decitabine 50 mg Injection in a single-dose vial.
What is Decitabine Injection used for?
Its approved uses depend on the country and product authorization. It is used in certain hematological malignancies, including MDS in the U.S. and specific AML settings in the EU.
Can hospitals purchase Decitabine Injection?
Yes. Hospitals and authorized healthcare procurement organizations can submit supply enquiries to Cordium Pharmaceuticals Pvt Ltd.
Can pharma distributors order Decitabine Injection?
Authorized pharmaceutical distributors and wholesalers can request quotations based on their required quantity and destination.
Is personal import available?
Personal import depends on the regulations of the destination country and may require a valid prescription or import authorization.
How can I get a competitive quotation?
Provide the required strength, quantity, destination country and buyer type to Cordium Pharmaceuticals Pvt Ltd for a quotation.
Request a Decitabine Injection Quote
For Decitabine Injection at competitive prices in Morocco, Kenya, Singapore, Australia, Germany, France, Canada and Saudi Arabia, contact Cordium Pharmaceuticals Pvt Ltd for product availability, quotation and export-support information.